Όλο το DSpace

Πλοήγηση ανά Θέμα "neuromuscular blocking"

Αποτελέσματα 1-3 από 3

    • COVID-19 ARDS: Points to be considered in mechanical ventilation and weaning 

      Kondili E., Makris D., Georgopoulos D., Rovina N., Kotanidou A., Koutsoukou A. (2021)
      The COVID-19 disease can cause hypoxemic respiratory failure due to ARDS, requiring invasive mechanical ventilation. Although early studies reported that COVID-19-associated ARDS has distinctive features from ARDS of other ...

    • Fixed dilated pupils in Covid-19 ARDS patients under rocuronium, reversed after discontinuation 

      Zakynthinos G.E., Tsolaki V., Bardaka F., Makris D. (2021)
      Neuromuscular Blockade Agents (NMBA) are used in the management of moderate and severe Acute Respiratory Distress Syndrome (ARDS) patients. They have never been reported to present Central Nervous System adverse reactions. ...

    • Neuromuscular Blockade in the Pre- and COVID-19 ARDS Patients 

      Tsolaki V., Zakynthinos G.E., Papadonta M.-E., Bardaka F., Fotakopoulos G., Pantazopoulos I., Makris D., Zakynthinos E. (2022)
      Acute respiratory distress syndrome (ARDS) accounts for a quarter of mechanically ventilated patients, while during the pandemic, it overwhelmed the capacity of intensive care units (ICUs). Lung protective ventilation (low ...